Repository logo
 
Publication

Neurobiology of Bipolar Disorder: Abnormalities on Cognitive and Cortical Functioning and Biomarker Levels

dc.contributor.authorde Sá, Alberto S
dc.contributor.authorCampos, Carlos
dc.contributor.authorRocha, Nuno
dc.contributor.authorYuan, Ti-Fei
dc.contributor.authorPaes, Flávia
dc.contributor.authorArias-Carrión, Oscar
dc.contributor.authorCarta, Mauro G
dc.contributor.authorNardi, Antonio E
dc.contributor.authorCheniaux, Elie
dc.contributor.authorMachado, Sergio
dc.date.accessioned2017-01-26T17:13:48Z
dc.date.available2017-12-01T01:30:15Z
dc.date.issued2016
dc.description.abstractBipolar disorder (BD) affects 1 to 1.5% of the world population and consists of at least one manic episode (or hypomanic) associated with depressive episodes, interspersed with periods of euthymic mood. Recurrent crises lead to significant disability in BD patients, and correlates negatively to social and occupational adjustment. Such disability can be explained by a series of events, such as cortical and altered metabolic activity, impairments in cognitive functions, and in core anatomical structures involved in mood modulation. Therefore, our review aims to provide information on the current research related to the pathophysiology of BD. We will review the cognitive and brain functioning, and biomarkers of BD. The current literature shows that cognitive deficits are commonly observed in all phases in BD patients, independent of a remissive state. These deficits are assigned to functional, structural and metabolic changes, particularly in the pre-frontal cortex region, hippocampus and amygdala, along with the connections between them, as well as decreased baseline brain-derived neurotrophic factor levels or imbalance between pro- and anti-inflammatory cytokines, implying a lower physical ability to reestablish from a stressful stimulus. BD patients effectively present a differentiated pattern of cortical, neuroanatomical and functional responses. It is suggested that physiological processes occur differently in bipolar subjects compared to healthy individuals, affecting behavior and brain function in such patients. Future directions are yet necessary to establish the best way to neutralize or reverse these events.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.2174/1871527315666160321111359pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/9466
dc.language.isoengpt_PT
dc.publisherBentham Science Publisherspt_PT
dc.subjectBipolar disorderpt_PT
dc.subjectbrain-derived neurotrophic factorpt_PT
dc.subjectdepressionpt_PT
dc.subjectmaniapt_PT
dc.subjectneuroplasticitypt_PT
dc.titleNeurobiology of Bipolar Disorder: Abnormalities on Cognitive and Cortical Functioning and Biomarker Levelspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue6pt_PT
oaire.citation.startPage713-22pt_PT
oaire.citation.titleCNS and Neurological Disorders - Drug Targetspt_PT
oaire.citation.volume15pt_PT
person.familyNameCampos
person.familyNameRocha
person.givenNameCarlos
person.givenNameNuno
person.identifier192266
person.identifier.ciencia-idB518-6A52-D50F
person.identifier.ciencia-idAE16-A494-5F8B
person.identifier.orcid0000-0002-5966-4050
person.identifier.orcid0000-0002-3139-2786
person.identifier.ridM-9821-2013
person.identifier.scopus-author-id56567519500
person.identifier.scopus-author-id32867975300
rcaap.rightsembargoedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationf9744770-c154-483e-b271-b58d1089d55f
relation.isAuthorOfPublication9e940914-601a-4978-8d5b-74e5ade7ada7
relation.isAuthorOfPublication.latestForDiscovery9e940914-601a-4978-8d5b-74e5ade7ada7

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ART_NunoRocha_TO_2016.pdf
Size:
745.39 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: